{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:19:09Z","timestamp":1787505549929,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10067-025-07352-9","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T22:28:16Z","timestamp":1739399296000},"page":"1705-1712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Salvage treatment of AOSD-associated macrophage activation syndrome with bariticinib following conventional immunosuppressive therapy"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9749-0006","authenticated-orcid":false,"given":"Ying","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TianDan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuancai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"7352_CR1","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1182\/blood.2019000936","volume":"135","author":"SW Canna","year":"2020","unstructured":"Canna SW, Marsh RA (2020) Pediatric hemophagocytic lymphohistiocytosis. Blood 135:1332\u20131343. https:\/\/doi.org\/10.1182\/blood.2019000936","journal-title":"Blood"},{"key":"7352_CR2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Dav\u00ec S et al (2016) 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European league against rheumatism\/American college of rheumatology\/paediatric rheumatology international trials organisation collaborative initiative. Arthritis Rheumatol 68:566\u2013576. https:\/\/doi.org\/10.1002\/art.39332","journal-title":"Arthritis Rheumatol"},{"key":"7352_CR3","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/s0022-3476(96)70140-3","volume":"129","author":"AA Grom","year":"1996","unstructured":"Grom AA, Passo M (1996) Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. J Pediatr 129:630\u2013632. https:\/\/doi.org\/10.1016\/s0022-3476(96)70140-3","journal-title":"J Pediatr"},{"key":"7352_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/adc.85.5.421","volume":"85","author":"S Sawhney","year":"2001","unstructured":"Sawhney S, Woo P, Murray KJ (2001) Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 85:421\u2013426. https:\/\/doi.org\/10.1136\/adc.85.5.421","journal-title":"Arch Dis Child"},{"key":"7352_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","volume":"12","author":"AA Grom","year":"2016","unstructured":"Grom AA, Horne A, De Benedetti F (2016) Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol 12:259\u2013268. https:\/\/doi.org\/10.1038\/nrrheum.2015.179","journal-title":"Nat Rev Rheumatol"},{"key":"7352_CR6","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/ard-2023-224123","volume":"82","author":"B Shakoory","year":"2023","unstructured":"Shakoory B, Geerlinks A, Wilejto M et al (2023) The 2022 EULAR\/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS). Ann Rheum Dis 82:1271\u20131285. https:\/\/doi.org\/10.1136\/ard-2023-224123","journal-title":"Ann Rheum Dis"},{"key":"7352_CR7","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/art.38802","volume":"66","author":"F Minoia","year":"2014","unstructured":"Minoia F, Dav\u00ec S, Horne A et al (2014) Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol 66:3160\u20133169. https:\/\/doi.org\/10.1002\/art.38802","journal-title":"Arthritis Rheumatol"},{"key":"7352_CR8","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/rheumatology\/keab673","volume":"61","author":"EL Verweyen","year":"2022","unstructured":"Verweyen EL, Schulert GS (2022) Interfering with interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA). Rheumatology (Oxford) 61:926\u2013935. https:\/\/doi.org\/10.1093\/rheumatology\/keab673","journal-title":"Rheumatology (Oxford)"},{"key":"7352_CR9","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1136\/ard-2024-225854","volume":"83","author":"S Bindoli","year":"2024","unstructured":"Bindoli S, De Matteis A, Mitrovic S, Fautrel B, Carmona L, De Benedetti F (2024) Efficacy and safety of therapies for Still\u2019s disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR\/PReS guidelines for the management of Still\u2019s disease. Ann Rheum Dis 83:1731\u20131747. https:\/\/doi.org\/10.1136\/ard-2024-225854","journal-title":"Ann Rheum Dis"},{"key":"7352_CR10","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1007\/s10067-018-4095-1","volume":"37","author":"HE S\u00f6nmez","year":"2018","unstructured":"S\u00f6nmez HE, Demir S, Bilginer Y, \u00d6zen S (2018) Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature. Clin Rheumatol 37:3329\u20133335. https:\/\/doi.org\/10.1007\/s10067-018-4095-1","journal-title":"Clin Rheumatol"},{"key":"7352_CR11","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s10067-023-06579-8","volume":"42","author":"K Irino","year":"2023","unstructured":"Irino K, Jinnouchi F, Nakano S, Sawabe T (2023) A case of hemophagocytic lymphohistiocytosis with a significant response to baricitinib: a first report with review of literature. Clin Rheumatol 42:1959\u20131963. https:\/\/doi.org\/10.1007\/s10067-023-06579-8","journal-title":"Clin Rheumatol"},{"key":"7352_CR12","doi-asserted-by":"publisher","first-page":"914265","DOI":"10.3389\/fimmu.2022.914265","volume":"13","author":"G Yi","year":"2022","unstructured":"Yi G, Huang Z, Huang Z, Wang Y, Deng W, Zheng S, Li T (2022) Case report: baricitinib as an alternative in the maintenance therapy for macrophage activation syndrome secondary to nodular panniculitis. Front Immunol 13:914265. https:\/\/doi.org\/10.3389\/fimmu.2022.914265","journal-title":"Front Immunol"},{"key":"7352_CR13","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.3390\/jcm10122633","volume":"10","author":"S Mitrovic","year":"2021","unstructured":"Mitrovic S, Fautrel B (2021) Clinical phenotypes of adult-onset Still\u2019s disease: new insights from pathophysiology and literature findings. J Clin Med 10:2633. https:\/\/doi.org\/10.3390\/jcm10122633","journal-title":"J Clin Med"},{"key":"7352_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","volume":"14","author":"E Feist","year":"2018","unstructured":"Feist E, Mitrovic S, Fautrel B (2018) Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease. Nat Rev Rheumatol 14:603\u2013618. https:\/\/doi.org\/10.1038\/s41584-018-0081-x","journal-title":"Nat Rev Rheumatol"},{"key":"7352_CR15","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/rheumatology\/keac440","volume":"62","author":"L Gillard","year":"2023","unstructured":"Gillard L, Pouchot J, Cohen-Aubart F, Kon\u00e9-Paut I, Mouterde G, Michaud M, Reumaux H, Savey L, Belot A, Fautrel B, Mitrovic S (2023) JAK inhibitors in difficult-to-treat adult-onset Still\u2019s disease and systemic-onset juvenile idiopathic arthritis. Rheumatology (Oxford) 62:1594\u20131604. https:\/\/doi.org\/10.1093\/rheumatology\/keac440","journal-title":"Rheumatology (Oxford)"},{"key":"7352_CR16","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1182\/blood-2015-12-684399","volume":"127","author":"R Das","year":"2016","unstructured":"Das R, Guan P, Sprague L et al (2016) Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis. Blood 127:1666\u20131675. https:\/\/doi.org\/10.1182\/blood-2015-12-684399","journal-title":"Blood"},{"key":"7352_CR17","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3324\/haematol.2020.253781","volume":"106","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Wei A, Ma HH et al (2021) A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis. Haematologica 106:1892\u20131901. https:\/\/doi.org\/10.3324\/haematol.2020.253781","journal-title":"Haematologica"},{"key":"7352_CR18","doi-asserted-by":"publisher","first-page":"e630","DOI":"10.1016\/s2352-3026(19)30156-5","volume":"6","author":"A Ahmed","year":"2019","unstructured":"Ahmed A, Merrill SA, Alsawah F et al (2019) Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. Lancet Haematol 6:e630\u2013e637. https:\/\/doi.org\/10.1016\/s2352-3026(19)30156-5","journal-title":"Lancet Haematol"},{"key":"7352_CR19","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/rheumatology\/key432","volume":"58","author":"M Gadina","year":"2019","unstructured":"Gadina M, Le MT, Schwartz DM, Silvennoinen O, Nakayamada S, Yamaoka K, O\u2019Shea JJ (2019) Janus kinases to jakinibs: from basic insights to clinical practice. Rheumatology (Oxford) 58:i4\u2013i16. https:\/\/doi.org\/10.1093\/rheumatology\/key432","journal-title":"Rheumatology (Oxford)"},{"key":"7352_CR20","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1172\/jci98814","volume":"128","author":"GAM Sanchez","year":"2018","unstructured":"Sanchez GAM, Reinhardt A, Ramsey S et al (2018) JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. J Clin Invest 128:3041\u20133052. https:\/\/doi.org\/10.1172\/jci98814","journal-title":"J Clin Invest"},{"key":"7352_CR21","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","volume":"100","author":"JI Henter","year":"2002","unstructured":"Henter JI, Samuelsson-Horne A, Aric\u00f2 M, Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D, Ladisch S, Webb D, Janka G (2002) Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 100:2367\u20132373. https:\/\/doi.org\/10.1182\/blood-2002-01-0172","journal-title":"Blood"},{"key":"7352_CR22","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.3899\/jrheum.200941","volume":"48","author":"A Horne","year":"2021","unstructured":"Horne A, Von Bahr GT, Chiang SCC, Meeths M, Bj\u00f6rklund C, Ekelund M, Erensj\u00f6 P, Berg S, Hagelberg S, Bryceson YT, Andersson U, Henter JI (2021) Efficacy of moderately dosed etoposide in macrophage activation syndrome-hemophagocytic lymphohistiocytosis. J Rheumatol 48:1596\u20131602. https:\/\/doi.org\/10.3899\/jrheum.200941","journal-title":"J Rheumatol"},{"key":"7352_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s12016-020-08786-6","volume":"59","author":"H You","year":"2020","unstructured":"You H, Xu D, Zhao J, Li J, Wang Q, Tian X, Li M, Zeng X (2020) JAK inhibitors: prospects in connective tissue diseases. Clin Rev Allergy Immunol 59:334\u2013351. https:\/\/doi.org\/10.1007\/s12016-020-08786-6","journal-title":"Clin Rev Allergy Immunol"},{"key":"7352_CR24","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1182\/blood-2004-08-2997","volume":"105","author":"AD Billiau","year":"2005","unstructured":"Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C (2005) Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-\u03b3-producing lymphocytes and IL-6- and TNF-\u03b1-producing macrophages. Blood 105:1648\u20131651. https:\/\/doi.org\/10.1182\/blood-2004-08-2997","journal-title":"Blood"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07352-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07352-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07352-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T06:54:43Z","timestamp":1744440883000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07352-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["7352"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07352-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Our research was granted an ethics exemption from the ethics committee of the First Affiliated Hospital of Soochow University because of the retrospective and noninterventional nature of the study. The study was based on existing data collected during routine clinical practice, and no additional risks were posed to the patients. Therefore, the need for individual informed consent was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}